Abstract: The present application relates to the administration of plasma, fractions thereof, or mixtures thereof to humans or animals to treat or otherwise improve cognitive impairment disorders, including dementia (e.g., vascular dementia, dementia with Lewy bodies, dementia resulting from Alzheimer's disease, dementia resulting from Parkinson's disease, frontotemporal dementia, and dementia resulting from normal pressure hydrocephalus in humans, and cognitive dysfunction syndrome in companion animals), concussion, and traumatic brain injury.
Type:
Grant
Filed:
May 17, 2018
Date of Patent:
July 4, 2023
Assignee:
APC EUROPE SLU
Inventors:
Francisco Javier Polo Pozo, Louis Edward Russell, María Carmen Rodríguez Canel, Joy Marlene Campbell, Joe David Crenshaw, Miquel Moretó Pedragosa, Anna Pérez Bosque, Lluïsa Miró Martí
Abstract: The present application relates to the administration of plasma, fractions thereof, or mixtures thereof to humans or animals to treat or otherwise improve cognitive impairment disorders, including dementia (e.g.
Type:
Application
Filed:
May 17, 2018
Publication date:
August 26, 2021
Applicant:
APC EUROPE SLU
Inventors:
Francisco Javier POLO POZO, Louis Edward RUSSELL, María Carmen RODRÍGUEZ CANEL, Joy Marlene CAMPBELL, Joe David CRENSHAW, Miquel MORETÓ PEDRAGOSA, Anna PÉREZ BOSQUE, Lluïsa MIRÓ MARTÍ